# Marken

A UPS Healthcare company operating across 43 countries with around 1,406 staff and roughly GBP 168.9 million in revenue, headquartered in Durham, North Carolina.

Source: https://en.bioecon.ru/companies/marken/
Updated: 2026-06-25

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | Marken is a subsidiary of United Parcel Service (UPS), and as such does not report separate independent funding rounds. | https://www.marken.com/, https://www.marken.com/who-we-are |
| Capacity | Operates 58 worldwide facilities, including 100,000+ square feet of GMP-compliant depot operations added in specific locations in 2021. [medium confidence] | https://www.prnewswire.com/news-releases/ups-healthcare-expands-global-cold-chain-logistics-network-301391344.html |
| Certification | Locations maintain ISO 27001:2022, ISO 14001:2015, ISO 13485, and ISO 9001 certifications. | https://marken-logistics.files.svdcdn.com/production/assets/PDFs/2024_Marken_Sustainability_Report.pdf?dm=1771618752, https://www.marken.com/capabilities/medical-device-logistics |
| Regulatory approval | Operations are GMP- and GDP-compliant. | https://www.marken.com/, https://www.marken.com/capabilities/medical-device-logistics, https://www.ncbiotech.org/news/marken-expands-durham-facility-amid-growing-demand-clinical-logistics, https://www.prnewswire.com/news-releases/ups-healthcare-expands-global-cold-chain-logistics-network-301391344.html |
| Production site | Operates a global network with 58+ facilities/locations worldwide. | https://www.ncbiotech.org/news/marken-expands-durham-facility-amid-growing-demand-clinical-logistics, https://www.prnewswire.com/news-releases/ups-healthcare-expands-global-cold-chain-logistics-network-301391344.html |
| Revenue | Reported revenue for Marken Limited was GBP 339 million in 2024; other sources estimate annual revenue in the range of GBP 168.9 million to over USD 900 million depending on reporting scope. [medium confidence] | https://pomanda.com/company/01485138/marken-limited |

Independent sources: ncbiotech.org, pomanda.com, prnewswire.com

## Technologies

- [Bio import/export customs brokerage](https://en.bioecon.ru/technology/bio-customs-brokerage/)
- [Biospecimen logistics for clinical trials](https://en.bioecon.ru/technology/biospecimen-logistics-for-clinical-trials/)
- [Cold chain for cell & gene therapies](https://en.bioecon.ru/technology/cold-chain-cell-gene-therapies/)
- [Hazardous biomaterials transport (IATA Class 6.2)](https://en.bioecon.ru/technology/hazardous-biomaterials-transport/)